Tuesday Mar 4
Boston Therapeutics to Initiate a Phase II Clinical Study of BTI-320 in U.S.
The Company expects the trial to last for approximately three months. The U.S.-based trial is intended to mirror the Company's study of BTI-320 currently enrolling patients in France.
Mon Mar 03, 2014
Almost 60% of diabetic nursing home residents with chronic kidney...
Nursing home residents who have diabetes and chronic kidney disease are commonly given medications that are not in keeping with best practice guidelines or prescribing information, according to recently published research.
Applied Clinical Trials
Oramed to Present Results from its Phase 2a FDA Trial with ORMD-0801...
Oramed to Present Results from its Phase 2a FDA Trial with ORMD-0801 at the 2014 Diabetes Summit on April 24, 2014 Oramed Pharmaceuticals Inc. , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be presenting detailed results from its recently completed Phase 2a FDA trial ... (more)
Medical News Today
New licensed treatment for Type 2 Diabetes launched in the UK with Cardiovascular Outcomes Evidence
Vipidia is a new DPP-4i for the management of Type 2 diabetes , launched in the UK with CV safety outcomes.1 Vipidia and the fixed dose combination product Vipdomet are now available in the UK.
Thu Feb 27, 2014
Once-Weekly Dulaglutide Non-Inferior to Liraglutide in Phase III Diabetes Trial
Positive results have been reported from the sixth AWARD trial of once-weekly dulaglutide, an investigational, long-acting glucagon-like peptide 1 receptor agonist being studied as a treatment for type 2 diabetes.
Tue Feb 25, 2014
Applied Clinical Trials
Lilly's Once-Weekly Dulaglutide Shows Non-Inferiority to Liraglutide...
In the AWARD-6 study, once-weekly dulaglutide 1.5 mg achieved the primary endpoint of non-inferiority to once-daily liraglutide 1.8 mg, as measured by the reduction of hemoglobin A1c from baseline at 26 weeks.
Mon Feb 24, 2014
A randomized controlled trial of the efficacy and safety of...
To compare the safety and efficacy of saxagliptin 2.5 mg twice daily versus placebo add-on therapy to metformin immediate release in patients with type 2 diabetes and inadequate glycemic control with metformin alone.
Sat Feb 22, 2014
Ask D'Mine: Mo' Metformin and Medicine Questions
This week, Wil offers some thoughts on mixing and matching your diabetes meds. Dan, type 1 from California, writes: Since type 1 diabetics are constantly dealing all their lives with the issue of glucose release after meals, at night, and whenever from our livers, why aren't we given metformin to control this process as a standard of care? Why is ... (more)
Liraglutide decreases carotid intima-media thickness in patients with ...
Liraglutide, a long-acting glucagon-like peptide-1 analog, has several non- glycemic properties, but its effect on carotid intima-media thickness , a recognized marker of subclinical atherosclerosis, is still unknown.
Fri Feb 21, 2014
Janssen-Cilag International NV Release: VOKANAMET...
Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use has adopted a positive opinion, recommending marketing authorisation in the European Union for the medicinal product VOKANAMETTM, a fixed-dose therapy combining canagliflozin and immediate release metformin in a single tablet, intended for the ... (more)
Thu Feb 20, 2014
Could Metabolism Be Linked to Epilepsy?
In a new study from Franciscan University in Steubenville, Ohio, researchers are exploring a possible link between metabolic defects and seizures.
Editorial illustrates shift away from glycemic control in diabetes treatment
This image shows the "lend a hand" illustration: an open palm facing out. The five major forms of diabetes interventions are arranged in descending order of importance from thumb to pinky.
Wed Feb 19, 2014
The Role Of Diet And Metabolism In Epilepsy: Fruit Fly Study Promises Hope For Treating Seizures
The fruit flies have done it again. Scientists have once again used the common lab insects known as Drosophila melanogaster to study the link between epilepsy and metabolism, by way of measuring fruit fly movement with inexpensive web-cams.
Could metabolism play a role in epilepsy?
The Kuehner lab demonstrates their drug-screening technique in JoVE 's peer-reviewed video format to aid other researchers in the field.
Tue Feb 18, 2014
Metabolomics Yield a Novel Biomarker for Predicting Diabetes Mellitus ...
Correspondence to Pankaj Arora, MD, Division of Cardiology, University of Alabama at Birmingham, 1808 7th Ave S, BDB 201, Birmingham, AL 35294.
Wed Feb 12, 2014
Reports Outline Cancer Therapy Findings from University of Illinois
Editor at Biotech Week -- Fresh data on Oncology are presented in a new report. According to news reporting out of , by NewsRx editors, research stated, "In the present study, we investigated the anticancer effects of the mitochondrial inhibitors, metaiodobenzylguanidine , metformin and phenformin.
Tue Feb 11, 2014
Metformin use doesn't cut incidence of bladder cancer
For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study published online Feb. 4 in Diabetes Care .
Fri Feb 07, 2014
Circulating MicroRNAs linked to type 2 diabetes
Circulating microRNAs are associated with type 2 diabetes , and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care .